- Home
- ELMD vs PBYI Comparison
ELMD vs PBYI Comparison
Compare ELMD & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- PBYI
- Stock Information
- Founded
- ELMD 1992
- PBYI 2010
- Country
- ELMD United States
- PBYI United States
- Employees
- ELMD N/A
- PBYI N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- PBYI Health Care
- Exchange
- ELMD Nasdaq
- PBYI Nasdaq
- Market Cap
- ELMD 172.2M
- PBYI 167.3M
- IPO Year
- ELMD 2010
- PBYI N/A
- Fundamental
- Price
- ELMD $22.05
- PBYI $3.38
- Analyst Decision
- ELMD Strong Buy
- PBYI Strong Buy
- Analyst Count
- ELMD 1
- PBYI 1
- Target Price
- ELMD $38.00
- PBYI $7.00
- AVG Volume (30 Days)
- ELMD 105.1K
- PBYI 379.0K
- Earning Date
- ELMD 05-13-2025
- PBYI 07-31-2025
- Dividend Yield
- ELMD N/A
- PBYI N/A
- EPS Growth
- ELMD 60.99
- PBYI 143.51
- EPS
- ELMD 0.79
- PBYI 0.77
- Revenue
- ELMD $61,439,000.00
- PBYI $232,709,000.00
- Revenue This Year
- ELMD $17.91
- PBYI N/A
- Revenue Next Year
- ELMD $11.70
- PBYI N/A
- P/E Ratio
- ELMD $27.64
- PBYI $4.36
- Revenue Growth
- ELMD 14.85
- PBYI 2.68
- 52 Week Low
- ELMD $13.74
- PBYI $2.23
- 52 Week High
- ELMD $35.56
- PBYI $4.13
- Technical
- Relative Strength Index (RSI)
- ELMD 60.57
- PBYI 48.53
- Support Level
- ELMD $20.00
- PBYI $3.25
- Resistance Level
- ELMD $22.35
- PBYI $3.39
- Average True Range (ATR)
- ELMD 0.70
- PBYI 0.15
- MACD
- ELMD 0.28
- PBYI -0.03
- Stochastic Oscillator
- ELMD 89.09
- PBYI 22.22
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.